(Total Views: 470)
Posted On: 09/02/2021 6:20:20 PM
Post# of 155008
This was removed from Reddit as "spam"
I guess Super-chet didn't like it...wonder why?
******
Enjoying the 13d schmooze?
Rosenbaum, the leader (78 or 79 yrs old) is going to spend the remainder of his life trying to help YOU, the ordinary shareholder. He brings along some side-kicks - two doctors that ran their mutually owned business almost into the ground (but always took their healthy salaries) they’re coming along “to help.” Then we have Dr. Patterson who appears to have been caught “patent pinching,” and a lady with a JD but no skin in the game…and they’ll all be working for YOU!
Right! Wanna buy a bridge?
Compare:
Current CytoDyn Leadership
In spite of coordinated opposition to CytoDyn’s leronlimab (Why – Leronlimab’s safety record and numerous applications makes it a sincere threat to numerous current and future Big Pharma product lines) things are progressing.
Current CytoDyn Team:
BLA for HIV now being completed pretty much as scheduled
Brazil Covid-19 Critical and Moderate (severe) trials starting soon
Recent stellar results for Triple Negative Breast Cancer
Recent stellar results for Long Hauler’s (PASC)
NASH completing approx.. Oct 20th
With no reverse splits, no massive dilution, respect for the ordinary shareholders, and sincere desire to make Leronlimab available for all!
IMO
I guess Super-chet didn't like it...wonder why?
******
Enjoying the 13d schmooze?
Rosenbaum, the leader (78 or 79 yrs old) is going to spend the remainder of his life trying to help YOU, the ordinary shareholder. He brings along some side-kicks - two doctors that ran their mutually owned business almost into the ground (but always took their healthy salaries) they’re coming along “to help.” Then we have Dr. Patterson who appears to have been caught “patent pinching,” and a lady with a JD but no skin in the game…and they’ll all be working for YOU!
Right! Wanna buy a bridge?
Compare:
Current CytoDyn Leadership
In spite of coordinated opposition to CytoDyn’s leronlimab (Why – Leronlimab’s safety record and numerous applications makes it a sincere threat to numerous current and future Big Pharma product lines) things are progressing.
Current CytoDyn Team:
BLA for HIV now being completed pretty much as scheduled
Brazil Covid-19 Critical and Moderate (severe) trials starting soon
Recent stellar results for Triple Negative Breast Cancer
Recent stellar results for Long Hauler’s (PASC)
NASH completing approx.. Oct 20th
With no reverse splits, no massive dilution, respect for the ordinary shareholders, and sincere desire to make Leronlimab available for all!
IMO
(16)
(0)
